Richard Fagerstrom, Ph.D., is a Mathematical Statistician in the Biometry Research Group.
Dr. Fagerstrom has expertise in clinical trials, cancer screening, computational biology, evolutionary medicine, and mathematical modeling. He was the Chief Statistician of the 10-site contractually funded side of the National Lung Screening Trial (NLST), leading all design, data collection, data management, and data analysis efforts. He also played a major role in the design and analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. In computational biology, he worked on the development of a pipeline searching for evidence of viral involvement in tumors represented in The Cancer Genome Atlas. He has also created mathematical models to support the decision of when to proceed from in vitro morphologic testing to animal testing in the development of cancer chemopreventive agents.
In addition to performing reviews of grant proposals and study protocols for the Division of Cancer Prevention (DCP), Dr. Fagerstrom serves as a Statistical Editor for Journal of the National Cancer Institute (JNCI) and a consultant for the China Cancer Screening Trial, the National Cancer Institute (NCI) Community Oncology Cardiotoxicity Task Force, and the US Preventive Services Task Force.
Dr. Fagerstrom received a Ph.D. in statistics from Florida State University and held positions in the Department of Biomathematical Sciences at Mount Sinai School of Medicine and the Reliability and Maintainability Methods group at Bell Communications Research before joining the Biometry Research Group in 1993.